BDX

195.96

0.51% 1.00

Handel nachbörslich: 195.96

Becton Dickinson Co (BDX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt BDX? Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$194.96

Offen:

$195.21

24-Stunden-Volumen:

2.67M

Relative Volume:

0.91

Marktkapitalisierung:

$56.17B

Einnahmen:

$21.39B

Nettoeinkommen (Verlust:

$1.61B

KGV:

35.24

EPS:

5.56

Netto-Cashflow:

$2.55B

1W Leistung:

+13.66%

1M Leistung:

+11.36%

6M Leistung:

-12.91%

1J Leistung:

-17.06%

1-Tages-Spanne:

$193.94

$196.27

1-Wochen-Bereich:

$184.21

$196.27

52-Wochen-Spanne:

$163.33

$251.99

Becton Dickinson Co Stock (BDX) Company Profile

Firmenname

Becton Dickinson Co

Sektor

Healthcare (1161)

Branche

Medical Instruments & Supplies (58)

Telefon

(201) 847-6800

Adresse

ONE BECTON DR, FRANKLIN LAKES

Mitarbeiter

74,000

Twitter

@BDandCo

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

BDX's Discussions on Twitter

Vergleichen Sie BDX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
BDX Becton Dickinson Co	195.96	55.88B	21.39B	1.61B	2.55B	5.56
ISRG Intuitive Surgical Inc	482.35	171.42B	9.15B	2.63B	1.99B	7.17
ALC Alcon Inc	86.48	42.55B	9.93B	1.12B	1.43B	2.26
RMD Resmed Inc	288.28	41.48B	5.15B	1.40B	1.65B	9.51
WST West Pharmaceutical Services Inc	246.22	17.25B	2.90B	467.20M	306.90M	6.37

Becton Dickinson Co Stock (BDX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-05-22	Herabstufung	Citigroup	Buy → Neutral
2025-05-02	Herabstufung	Goldman	Buy → Neutral
2025-05-02	Herabstufung	Piper Sandler	Overweight → Neutral
2025-05-02	Herabstufung	Raymond James	Outperform → Mkt Perform
2025-05-01	Herabstufung	BofA Securities	Buy → Neutral
2025-05-01	Herabstufung	Wells Fargo	Overweight → Equal Weight
2025-05-01	Herabstufung	William Blair	Outperform → Mkt Perform
2024-10-01	Hochstufung	Citigroup	Neutral → Buy
2024-05-30	Eingeleitet	Goldman	Buy
2023-07-24	Hochstufung	Raymond James	Mkt Perform → Outperform
2023-05-30	Fortgesetzt	Morgan Stanley	Overweight
2023-05-05	Hochstufung	Piper Sandler	Neutral → Overweight
2023-04-12	Hochstufung	KeyBanc Capital Markets	Sector Weight → Overweight
2023-01-03	Hochstufung	BofA Securities	Neutral → Buy
2022-12-12	Hochstufung	Citigroup	Sell → Neutral
2022-07-11	Herabstufung	Citigroup	Neutral → Sell
2022-06-24	Hochstufung	Wells Fargo	Equal Weight → Overweight
2022-03-18	Fortgesetzt	Raymond James	Mkt Perform
2022-03-02	Fortgesetzt	BofA Securities	Neutral
2021-12-08	Herabstufung	Piper Sandler	Overweight → Neutral
2021-08-06	Herabstufung	JP Morgan	Overweight → Neutral
2021-05-25	Eingeleitet	Barclays	Equal Weight
2020-12-15	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2020-12-15	Herabstufung	Wells Fargo	Overweight → Equal Weight
2020-07-09	Hochstufung	Barclays	Equal Weight → Overweight
2020-06-01	Fortgesetzt	Goldman	Buy
2020-03-05	Eingeleitet	Citigroup	Neutral
2020-02-07	Herabstufung	Cowen	Outperform → Market Perform
2020-02-07	Herabstufung	KeyBanc Capital Markets	Overweight → Sector Weight
2020-02-07	Herabstufung	Raymond James	Strong Buy → Outperform
2020-02-06	Herabstufung	Cowen	Outperform → Market Perform
2020-01-08	Herabstufung	Barclays	Overweight → Equal Weight
2019-05-13	Hochstufung	Barclays	Equal Weight → Overweight
2018-12-07	Eingeleitet	Deutsche Bank	Buy
2018-10-16	Eingeleitet	Barclays	Equal Weight
2018-06-21	Hochstufung	JP Morgan	Neutral → Overweight
2018-04-10	Hochstufung	Citigroup	Neutral → Buy
2018-01-19	Fortgesetzt	BofA/Merrill	Buy
2018-01-05	Hochstufung	Citigroup	Sell → Neutral
2018-01-05	Eingeleitet	KeyBanc Capital Mkts	Overweight
2018-01-03	Eingeleitet	Evercore ISI	Outperform
2017-12-29	Bestätigt	Deutsche Bank	Buy

Alle ansehen

Becton Dickinson Co Aktie (BDX) Neueste Nachrichten

08:00 AM

Clinical Microbiology Market to Reach $6.9 Billion by 2029, Driven by Advanced Diagnostics and Regulatory Demand | MarketsandMarkets™. - GlobeNewswire Inc.

08:00 AM

Aug 12, 2025

Diamond Hill Capital's Strategic Moves: Significant Reduction in Becton Dickinson & Co - Yahoo Finance

Aug 12, 2025

Aug 11, 2025

Director’s Bold Move: A Million-Dollar Bet on Becton Dickinson! - TipRanks

Aug 11, 2025

Judge OKs Becton Dickinson's $9M Investor Settlement - Law360

Aug 11, 2025

Aug 10, 2025

4 Overlooked Dividend Aristocrat Stocks with Up To 60%+ Growth Potential - 24/7 Wall St.

Aug 10, 2025

BD Careers | Jobs at BD | We are the Makers of Possible - Becton Dickinson

Aug 10, 2025

Aug 09, 2025

Earnings Beat: Becton, Dickinson and Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - 富途牛牛

Aug 09, 2025

Piper Sandler Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Raises Target Price to $200 - 富途牛牛

Aug 09, 2025

Aug 08, 2025

Director Makes Significant Move with Becton Dickinson Stock! - TipRanks

Aug 08, 2025

J.P. Morgan Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Raises Target Price to $190 - 富途牛牛

Aug 08, 2025

A Quick Look at Today's Ratings for Becton Dickinson & Co(BDX.US), With a Forecast Between $183 to $200 - 富途牛牛

Aug 08, 2025

Becton Dickinson: Wells Fargo maintains Equal-Weight, raises PT to $184 from $172. - AInvest

Aug 08, 2025

Becton, Dickinson and Company (NYSE:BDX) Q3 2025 Earnings Call Transcript - Insider Monkey

Aug 08, 2025

Becton Dickinson price target raised to $200 from $185 at Piper Sandler - TipRanks

Aug 08, 2025

Piper Sandler raises Becton Dickinson stock price target to $200 on earnings beat - Investing.com

Aug 08, 2025